R
Rakel López de Maturana
Researcher at Netherlands Cancer Institute
Publications - 8
Citations - 323
Rakel López de Maturana is an academic researcher from Netherlands Cancer Institute. The author has contributed to research in topics: LRRK2 & Mutation. The author has an hindex of 7, co-authored 8 publications receiving 277 citations.
Papers
More filters
Journal ArticleDOI
The LRRK2 G2019S mutant exacerbates basal autophagy through activation of the MEK/ERK pathway.
José Manuel Bravo-San Pedro,Mireia Niso-Santano,Rubén Gómez-Sánchez,Elisa Pizarro-Estrella,Ana Aiastui-Pujana,Ana Gorostidi,Vicente Climent,Rakel López de Maturana,Rosario Sanchez-Pernaute,Adolfo López de Munain,José M. Fuentes,Rosa A. González-Polo +11 more
TL;DR: Data suggest that the G2019S mutation induces autophagy via MEK/ERK pathway and that the inhibition of this exacerbated autophagic activity reduces the sensitivity observed in G 2019S mutant cells.
Journal ArticleDOI
Mutations in LRRK2 impair NF-κB pathway in iPSC-derived neurons
Rakel López de Maturana,Valérie Lang,Amaia Zubiarrain,A C Sousa,Nerea Vazquez,Ana Gorostidi,Julio Aguila,Adolfo López de Munain,Adolfo López de Munain,Manuel J. Rodriguez,Rosario Sanchez-Pernaute +10 more
TL;DR: The results show that LRRK2 mutations affect α-synuclein regulation and impair NF-κB canonical signaling in iPSC-derived neurons, strengthening the link between L RRK2 and the innate immunity system underscoring the involvement of inflammatory pathways in the neurodegenerative process in PD.
Journal ArticleDOI
Leucine-rich repeat kinase 2 modulates cyclooxygenase 2 and the inflammatory response in idiopathic and genetic Parkinson's disease.
Rakel López de Maturana,Julio Aguila,A C Sousa,Nerea Vazquez,Patricia del Rio,Ana Aiastui,Ana Gorostidi,Adolfo López de Munain,Rosario Sanchez-Pernaute +8 more
TL;DR: Multiple defects in inflammatory pathways in which LRRK2 appears to be critically involved are described, including weak induction of pro-inflammatory cytokines and reduced NFκB transcriptional activation.
Journal ArticleDOI
iPS Cell Cultures from a Gerstmann-Sträussler-Scheinker Patient with the Y218N PRNP Mutation Recapitulate tau Pathology
Andreu Matamoros-Angles,Lucía Mayela Gayosso,Yvonne Richaud-Patin,Angelique di Domenico,Cristina Vergara,Arnau Hervera,A C Sousa,Natalia Fernández-Borges,Antonella Consiglio,Antonella Consiglio,Rosalina Gavín,Rakel López de Maturana,Isidro Ferrer,Adolfo López de Munain,Angel Raya,Joaquín Castilla,Rosario Sanchez-Pernaute,José Antonio del Río +17 more
TL;DR: Whether iPS cell-derived neurons could be used to investigate the appearance of disease-related phenotypes (i.e, tauopathy) identified in the GSS patient is tested for the first time.
Journal ArticleDOI
LRRK2 Expression Is Deregulated in Fibroblasts and Neurons from Parkinson Patients with Mutations in PINK1
Garikoitz Azkona,Rakel López de Maturana,Patricia del Rio,A C Sousa,Nerea Vazquez,Amaia Zubiarrain,Daniel Jimenez-Blasco,Juan P. Bolaños,Blas Morales,Georg Auburger,José Matías Arbelo,Rosario Sanchez-Pernaute +11 more
TL;DR: A novel role of PINK1 modulating the levels of L RRK2 in Parkinson’s disease fibroblasts and neurons is identified, a convergent pathway for these PARK genes is suggested, and the role of LRRK2 is broadened in the pathogenesis of Parkinson's disease.